Invesco Ltd. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,290,986
-24.8%
2,902,440
+66.0%
0.01%
-25.0%
Q2 2023$44,262,762
+520.2%
1,748,825
+689.3%
0.01%
+500.0%
Q1 2023$7,136,641
+481.9%
221,566
+233.5%
0.00%
Q4 2022$1,226,390
-81.1%
66,435
-72.4%
0.00%
-100.0%
Q3 2022$6,498,000
+647.8%
240,690
+282.7%
0.00%
Q2 2022$869,000
-79.6%
62,888
-71.2%
0.00%
-100.0%
Q1 2022$4,258,000
+562.2%
218,346
+454.3%
0.00%
Q4 2021$643,000
-45.2%
39,391
-6.4%
0.00%
Q3 2021$1,173,000
+7.8%
42,074
+14.7%
0.00%
Q2 2021$1,088,000
+45.8%
36,697
+37.5%
0.00%
Q1 2021$746,000
+87.4%
26,685
+90.3%
0.00%
Q4 2020$398,000
-56.0%
14,020
-61.0%
0.00%
Q3 2020$904,000
+16.9%
35,965
+13.5%
0.00%
Q2 2020$773,000
+300.5%
31,677
+167.0%
0.00%
Q4 2019$193,000
+17.7%
11,866
-6.1%
0.00%
Q3 2019$164,000
-3.5%
12,634
-3.7%
0.00%
Q2 2019$170,000
-43.5%
13,126
-31.3%
0.00%
Q1 2019$301,000
-88.2%
19,107
-77.0%
0.00%
-100.0%
Q1 2018$2,559,000
+110.6%
83,097
+19.4%
0.00%
Q1 2016$1,215,000
+24200.0%
69,594
+43126.1%
0.00%
Q2 2015$5,0001610.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$156,130,00032.47%
Camber Capital Management LP 630,000$21,420,0001.40%
Granite Point Capital Management, L.P. 50,000$1,700,0001.17%
Rhenman & Partners Asset Management AB 82,000$2,788,0000.83%
Geduld E E 25,001$850,0000.53%
Pier Capital, LLC 106,985$3,637,0000.52%
Ghost Tree Capital, LLC 20,000$680,0000.48%
ArrowMark Colorado Holdings LLC 433,457$14,738,0000.42%
Polar Capital LLP 577,042$19,618,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,500$8,721,0000.35%
View complete list of REVANCE THERAPEUTICS INC shareholders